Nice animation of our science and approach to developing a new class of medicines.

Two brilliant, enlightened appointments

Early start for Heckington show. Everyone in their pens ready for showing Serafeena

Successful day at Heckington with a 1,2 in the ram 🐏 class. Great work by Serafeena

Many thanks to Endpoints News Lei Lei Wu for covering our #ESMO24 abstracts and our ambitions for our lead investigational therapy for #bladder cancer. Read the full article: endpts.com/bicycle-therap….

Delighted to collect the Business Weekly investment of the year award on behalf of Bicycle Therapeutics

Some great questions from Greg Lawton to which I would add - What can a Royal College do that the Royal Pharmaceutical Society cannot do in its current form? What benefits will members see? Will the PLB insist on restricting membership to GPhC regulated professionals? How much will this cost?

Happy Friday

Happy Monday.

Delighted to be joining the BioIndustry Association (BIA) board at such an exciting time for the industry and Bicycle Therapeutics

📢 Dive into the implications of #Budget2024 with expert analysis on what the latest announcements mean for the #biotech and life sciences sectors! Join us next Thursday! ➡️ bioindustry.org/events/our-eve… 🗓 7 November 🕒 11:30-12:30 GMT 💻 Online

Happy Friday, have a great weekend

Today during #SABCS24, we announced data updates for zelenectide pevedotin in #BreastCancer, #lung #cancer & #bladdercancer. Join our investor call tomorrow at 8 a.m. ET where we’ll review & discuss the data. Read more here: bit.ly/41wjLWv.

More exciting clinical data on Zelenectide.

Significant data from Niklas Klümper and team on Zelenectide in heavily pretreated breast cancer patients with Nectin-4 amplification showing an ORR of 57.1% Bicycle Therapeutics

If the proposed government building programme demands #PassiveHaus standards there is a real possibility to eliminate fuel poverty and directly improve health outcomes Sir Michael Marmot

Lovely view from the office this morning as the snow starts to clear. Not much chance of work on the hard landscaping until tomorrow

DYK: Bicycle molecules can be used to develop potential treatments for diseases affecting the skeletal muscle and heart? New preclinical data with our partner Ionis demonstrates the expansive potential of our Bicycle technology. More here: bit.ly/4jwUSzO